Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Mereo BioPharma Group plc due to alleged violations of federal securities laws related to misleading statements about clinical trial results [2][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Mereo BioPharma to contact them to discuss their legal options [1]. - There is a deadline of April 6, 2026, for investors to seek the role of lead plaintiff in a federal securities class action against Mereo [2][7]. Group 2: Clinical Trial Results - Mereo announced that two Phase 3 studies of setrusumab failed to meet their primary endpoints of reducing annualized clinical fracture rates compared to placebo and bisphosphonates [5]. - Despite the failure to meet primary endpoints, the trials showed statistically significant improvements in bone mineral density on secondary endpoints, and no new safety concerns were identified [5]. Group 3: Market Reaction - Following the announcement of the failed trials, Mereo's stock price fell by $2.02 per share, or 87.64%, closing at $0.28 per share on December 29, 2025 [6].

Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation on behalf of purchasers of its Class A common stock between May 13, 2025, and November 6, 2025, due to alleged misleading statements and undisclosed risks related to its commercialization strategy [1][5]. Group 1: Lawsuit Details - The lawsuit claims that NuScale's partner, ENTRA1 Energy LLC, had no significant experience in building or operating nuclear power projects, which was not disclosed to investors [5]. - It is alleged that NuScale misrepresented the qualifications of ENTRA1, attributing experience to the Habboush Group, which also lacked relevant expertise in nuclear power generation [5]. - The lawsuit asserts that these misrepresentations exposed NuScale's commercialization strategy to undisclosed risks, leading to investor damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased NuScale Class A common stock during the specified period may be eligible for compensation without any out-of-pocket costs through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by April 20, 2026, to represent the interests of the class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm, which is leading the class action, has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its success in securities class action settlements and has consistently ranked among the top firms in this area since 2013 [4].

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026. SO WHAT: If you purchased NuScale Class A common stock during the Class P ...

Core Points - A class action lawsuit has been filed against CoreWeave, Inc. for alleged securities fraud during the Class Period from March 28, 2025, to December 15, 2025 [1] - Investors who purchased CoreWeave securities during this period and suffered losses have until March 13, 2026, to seek appointment as lead plaintiff [2] - The lawsuit claims that CoreWeave made misleading statements regarding its ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [4] Allegations - CoreWeave is accused of overstating its capacity to meet customer demand for its AI cloud computing services [4] - The company allegedly failed to disclose the significant risks posed by its dependence on a single third-party data center, which could negatively impact its revenue [4] - The lawsuit suggests that these misrepresentations led to substantial losses for investors when the truth was revealed [5] Company Background - CoreWeave is positioned as an AI cloud computing company and announced a significant deal worth up to $11.9 billion with OpenAI shortly before its IPO [3] - The company also announced an agreement to acquire Core Scientific, a major player in digital infrastructure for high-performance computing, in an all-stock transaction [3]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Apollo Global Management, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by an article from Financial Times stating that Apollo executives, including CEO Marc Rowan, had discussions regarding tax arrangements with Jeffrey Epstein, despite previous claims of no business dealings with him [3]. - Following the news, Apollo's stock experienced a decline of 1% on February 2, 2026, and a further drop of 4.76% on February 3, 2026 [3]. Group 2: Class Action Information - Shareholders who purchased Apollo securities may be eligible for compensation through a class action lawsuit without any out-of-pocket fees, facilitated by a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

Group 1 - A class action lawsuit has been announced by Rosen Law Firm on behalf of purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) during the Class Period from May 13, 2025, to November 6, 2025 [1] - Investors who purchased NuScale Class A common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - The lawsuit alleges that NuScale made false and misleading statements regarding its partnership with ENTRA1 Energy LLC, which lacked significant experience in nuclear power generation, exposing NuScale's commercialization strategy to undisclosed risks [5] Group 2 - To join the NuScale class action, interested parties can visit the provided link or contact Phillip Kim, Esq. for more information [3][6] - The Rosen Law Firm has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors and being recognized for its success in this field [4] - No class has been certified yet, and investors are advised that they are not represented by counsel unless they retain one [7]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Enphase Energy, Inc. securities for the period between April 22, 2025, and October 28, 2025, due to alleged misleading statements and failure to disclose critical information [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Enphase overstated its ability to manage channel inventory and mitigate the effects of the termination of the Residential Clean Energy Credit, leading to materially false and misleading public statements [5]. - Investors who purchased Enphase securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by April 20, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Nidec Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased Nidec securities, with no out-of-pocket fees through a contingency fee arrangement [2]. - The investigation follows a significant drop in Nidec's stock price, which fell 22.7% after a probe into accounting issues was announced [3]. Group 2: Company Background and Legal Expertise - Nidec Corporation is facing scrutiny due to allegations of improper accounting practices within its group, leading to the largest one-day drop in its shares [3]. - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and recovering hundreds of millions for investors [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased GSI Technology securities, with no out-of-pocket fees through a contingency fee arrangement [2]. - A post on Stockwits alleged that GSI Technology's chip did not run the Gemma-3 as claimed, leading to a significant stock price drop of $1.08 per share, or 14.2%, closing at $6.52 on February 4, 2026 [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has consistently ranked in the top 4 for securities class action settlements since 2013 [4].

Core Points - Rosen Law Firm is reminding purchasers of CoreWeave, Inc. securities from March 28, 2025, to December 15, 2025, about the lead plaintiff deadline on March 13, 2026 [1] - Investors who purchased CoreWeave securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has been filed against CoreWeave, and interested parties can join by contacting Rosen Law Firm [3][6] Case Details - The lawsuit alleges that CoreWeave's defendants made false and misleading statements regarding the company's ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [5] - It is claimed that these misstatements were likely to have a material negative impact on CoreWeave's revenue, leading to investor damages when the truth was revealed [5] Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions, as many firms may not have the necessary experience [4] - Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [4]